Allnex buys Bayer's radiation curing resins business

Allnex, which bought Cytec's Coating Resins business earlier this year, is acquiring Bayer MaterialScience's Desmolux non-waterborne radiation curing resins business.

Related Suppliers

Allnex (Brussels, Belgium) announced on July 18 that it has signed an agreement to acquire Bayer MaterialScience’s (Munich, Germany) non-waterborne radiation curing resins business, marketed under the Desmolux brand and representing a specialized portfolio of radiation curing oligomers suitable for higher performance uses.

The Desmolux product portfolio includes non-waterborne radiation curing acrylated resins and radiation curing unsaturated polyesters in acrylated diluents. The acquisition of the Desmolux product portfolio will complement Allnex’s position in EBECRYL UV/EB radiation curing products and will enable Allnex to further enhance its technology leadership as it continues to address future customer needs. Allnex also says it will increase its presence in new applications, develop new markets for radiation cure and globalize the Desmolux business.

The deal is expected to be closed in the second half of 2013.

“We are excited about combining Bayer’s Desmolux business with Allnex’s existing Radcure product portfolio,” states CEO of Allnex, Frank Aranzana. “The divestiture of the Coating Resins business of Cytec into Allnex was only completed on April 3, 2013 and we are already taking another step towards establishing the company’s new identity. This transaction will extend our portfolio of products and add new revenue streams enabling Allnex to further leverage its strong customer relationships and partner network to expand distribution worldwide.”

A global company with $1.5 billion in sales, Allnex is a supplier of resins for architectural, industrial, OEM and special purpose coatings.